The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study--the Iran subgroup of the IMPROVE™ study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples